NFKB1 and esophageal squamous cell carcinoma: Furthermore, treatment of ESCC cells with Erk (PD98059) or NF-κB (Bay11-7082) pathway inhibitors attenuated the BGN-induced enhancement of proliferation and migration (Figure 3B,C).